Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

Mok T.Wu Y.-L.Lee J.S.CHONG-JEN YUSriuranpong V.Sandoval-Tan J.Ladrera G.Thongprasert S.Srimuninnimit V.Liao M.Zhu Y.Zhou C.Fuerte F.Margono B.Wen W.Tsai J.Truman M.Klughammer B.Shames D.S.Wu L.2022-06-272022-06-2720151078-0432https://www.scopus.com/inward/record.uri?eid=2-s2.0-84938399710&doi=10.1158%2f1078-0432.CCR-14-2594&partnerID=40&md5=8c0ae640d615edf0355c159967edfd40https://scholars.lib.ntu.edu.tw/handle/123456789/614165[SDGs]SDG3Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapyjournal article10.1158/1078-0432.CCR-14-2594258293972-s2.0-84938399710